RX

Research and Markets: Chugai IMS Company Profile - Now Available - 12/01 - 11:03 AM ET

Actavis Receives Approval of Generic Wellbutrin XL(R) 150mg in the U.S. - 12/01 - 08:00 AM ET

Research and Markets: This Essential Teva IMS Company Profile is Now Available - 11/28 - 07:56 AM ET

China to Be No. 5 Pharmaceutical Market in 2012 - 11/28 - 06:12 AM ET

New Study Highlights Rising Number of Type 2 Diabetes Patients in U.S., Increasing Complexity of Treatments - 11/18 - 12:22 PM ET

RX: To Present At Credit Suisse Healthcare Conference @ 12:30 ET [delayed] - 11/12 - 10:53 AM ET

BIOTECHNICA AMERICA, INTERPHEX and PharmaMedDevice Host Joint Life Sciences Event in New York for the First Time - 11/06 - 05:03 AM ET

IMS to Present at Credit Suisse Conference on November 12 at 10:30 a.m. MST - 11/05 - 09:11 PM ET

Pharma sales to grow 1% to 2% in '09 - 10/30 - 05:06 AM ET

Pharma sales outlook lowered for '09 - 10/29 - 12:38 PM ET

UPDATE 1-IMS Health posts 33 pct rise in quarterly profit - 10/23 - 07:55 AM ET

RX: Q3 Earnings Call @ 08:00 ET Today [delayed] - 10/23 - 07:29 AM ET

FDA delays review of Takeda's heartburn drug - 10/23 - 07:27 AM ET

BRIEF-IMS Health Q3 results - 10/23 - 07:20 AM ET

IMS HEALTH INC REUTERS ESTIMATES Q3 SHR VIEW $0.42, REV VIEW $597.13 MLN - 10/23 - 07:14 AM ET

IMS HEALTH INC Q3 NON-GAAP SHR $0.43 - 10/23 - 07:12 AM ET

IMS HEALTH INC Q3 GAAP SHR $0.41 - 10/23 - 07:12 AM ET

IMS HEALTH INC Q3 REVENUE ROSE 6 PCT TO $573.7 MLN - 10/23 - 07:12 AM ET

IMS Health announces dividend for Q4 - 10/22 - 05:39 AM ET

IMS Sets Fourth-Quarter 2008 Dividend - 10/21 - 05:34 PM ET

Page 1 of 12     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index